Lancet paper critique – Part 3

Finally, you may think, some figures. In this blog I want to look at some of the figures on adverse effects seen in a number of statin trials such figures as it is possibly to unearth anyway. Unlike the CTT in Oxford I along with almost every other researcher in the world [ ]